Return to Search
Section 4461, Payment for Intravenous Iron Replacement Therapy Drugs
Guidance for Section 4461, Payment for Intravenous Iron Replacement Therapy Drugs, a new section developed to provide instruction for payment of these types of drugs.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: June 01, 2001
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.